Document:

Amended and Restated Executive Employment Agreement

 Exhibit 10.18 
 AMENDED AND RESTATED 
 EXECUTIVE EMPLOYMENT AGREEMENT 
 This Amended and Restated Executive Employment Agreement (this “Agreement”), dated as of November 17, 2008 (the “Effective
Date”), is made by and between Constar International Inc., a Delaware corporation, having its principal offices at One Crown Way, Philadelphia, Pennsylvania 19154 (the “Company”), and Mr. Walter Sobon (the “Executive”).

 RECITALS 
 WHEREAS, the
Executive is currently employed by the Company pursuant to the terms of an Employment Agreement dated December 12, 2005 (the “Original Agreement”); 
 WHEREAS, the Company desires to assure itself of the continued employment of the Executive and to encourage his continued attention and dedication to the best interests of the Company, by replacing the Original
Agreement with this amended and restated Agreement; and 
 WHEREAS, the Executive desires to remain and continue in the employment of the
Company in accordance with the terms of this Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained, and intending to be legally bound hereby, the Company and the
Executive hereby agree as follows: 
 1. Definitions. 
 1.1. “Affiliate” means any person or entity controlling, controlled by or under common control with the Company. 
 1.2. “Board” means the Board of Directors of the Company. 
 1.3. “Cause” means (a) the Executive, in carrying out his duties under this Agreement, engages in gross misconduct or gross negligence resulting in a material adverse effect on the Company, (b) the
Executive embezzles any amount of the Company’s assets, (c) the Executive is convicted (including a plea of guilty or nolo contendere) of a felony involving moral turpitude, (d) the Executive’s breach of any covenant contained in
Section 9 below, or (e) the Executive’s willful and material failure to follow the lawful instructions of the Company’s Board (consistent with Section 4 below). For purposes of this Section 1.3, no act, or failure to
act, on the Executive’s part shall be considered “willful” unless done, or omitted to be done, by him in bad faith and without reasonable belief that his action or omission was in the best interest of the Company. Any act or omission
to act by the Executive in reliance upon an opinion of counsel to the Company shall not be deemed to be willful. 

 1.4. “Change in Control” shall mean: 
 1.4.1. the acquisition after the Effective Date by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934 (the “Exchange Act”)) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 30% of the combined voting power of the voting securities of the Company
entitled to vote generally in the election of directors (the “Voting Securities”); provided, however, that the following acquisitions shall not constitute a Change in Control: (a) any acquisition, directly or indirectly by or from the
Company or any subsidiary of the Company, or by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary of the Company, (b) any acquisition by any underwriter in connection with any firm commitment
underwriting of securities to be issued by the Company, or (c) any acquisition by any corporation if, immediately following such acquisition, 70% or more of the then outstanding shares of common stock of such corporation and the combined voting
power of the then outstanding voting securities of such corporation (entitled to vote generally in the election of directors), are beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who,
immediately prior to such acquisition, were the beneficial owners of the then outstanding common stock of the Company (“Common Stock”) and the Voting Securities in substantially the same proportions, respectively, as their ownership,
immediately prior to such acquisition, of the Common Stock and Voting Securities; or 
 1.4.2. The occurrence after the Effective Date of a
reorganization, merger or consolidation, other than a reorganization, merger or consolidation with respect to which all or substantially all of the individuals and entities who were the beneficial owners, immediately prior to such reorganization,
merger or consolidation, of the Common Stock and Voting Securities, beneficially own, directly or indirectly, immediately after such reorganization, merger or consolidation, 70% or more of the then outstanding common stock and voting securities
(entitled to vote generally in the election of directors) of the corporation resulting from such reorganization, merger or consolidation in substantially the same proportions as their respective ownership, immediately prior to such reorganization,
merger or consolidation, of the Common Stock and Voting Securities; or 
 1.4.3. The occurrence after the Effective Date of (a) a
complete liquidation or substantial dissolution of the Company, or (b) the sale or other disposition of all or substantially all of the assets of the Company, in each case other than to a subsidiary, wholly-owned, directly or indirectly, by the
Company or to a holding company of which the Company is a direct or indirect wholly owned subsidiary prior to such transaction; or 
 1.4.4.
During any period of twenty-four (24) consecutive months commencing upon the Effective Date, the individuals at the beginning of any such period 

  

 -2- 

 
who constitute the Board and any new director (other than a director designated by a person or entity who has entered into an agreement with the Company or
other person or entity to effect a transaction described in Sections 1.4.1, 1.4.2 or 1.4.3 above) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds ( 2/3) of the directors then still in office who either were directors at the beginning of any such period or whose election or
nomination for election was previously so approved, cease for any reason to constitute a majority of the Board. 
 Notwithstanding the above, a
“Change in Control” shall not include any event, circumstance or transaction which results from the action of any entity or group which includes, is affiliated with or is wholly or partially controlled by one or more executive officers of
the Company and in which the Executive participates. 
 1.5. “Disability” means the Executive’s inability to render, for a
period of six consecutive months, services hereunder by reason of physical or mental disability, as determined by the written medical opinion of an independent medical physician mutually acceptable to the Executive and the Company. If the Executive
and the Company cannot agree as to such an independent medical physician, each shall appoint one medical physician and those two physicians shall appoint a third physician who shall make such determination. In no event shall the Executive be
considered disabled for the purposes of this Agreement unless the Executive is deemed disabled pursuant to the Company’s long-term disability plan, if one is maintained by the Company. 
 1.6. “Good Reason” means and shall be deemed to exist if, without the prior express written consent of the Executive, (a) the Executive
suffers a material adverse change in his reporting obligations, (b) the Executive suffers a material adverse change in the duties, responsibilities or effective authority associated with his titles and positions, as set forth and described in
Section 4 of this Agreement; (c) a reduction by the Company of the Executive’s “Base Salary” (as increased from time to time in accordance with Section 5.1 below) or in the other compensation and benefits (except for
benefits payable under the Company’s equity, incentive or bonus plans) below a level which is substantially equivalent in the aggregate, to those payable to the Executive hereunder, or a material adverse change in the terms or conditions on
which any such compensation or benefits are payable as in effect on the date hereof or as the same may be increased from time to time during the term of this Agreement; (d) the Company discontinues the AIMSPP without immediately replacing such plan
with a plan that is the substantial economic equivalent of such plan; (e) the Company fails to pay the accrued Executive’s compensation or to provide for the Executive’s accrued benefits when due; (f) the Executive’s office
location is moved to a location more than 30 miles from Philadelphia, Pennsylvania; or (g) the failure or refusal of the “Company’s Successor” (as defined in Section 8.2 below) to expressly assume this Agreement in writing,
and all of the duties and obligations of the Company hereunder in accordance with Section 8.2. 
 1.7. “Restricted Period”
means the Term of Employment, plus (a) in the event the Executive’s employment is terminated pursuant to Section 6.4, the twenty-four (24) month period immediately following such termination; or (b) in the event the
Executive’s employment is terminated for any other reason, the twelve (12) month period immediately following Executive’s termination of employment. 
  

 -3- 

 2. Employment. Subject to the terms and provisions set forth in this Agreement and
specifically as provided in Section 4.1, the Company hereby agrees that the Executive shall during the “Term of Employment” (as defined in Section 3 below) be employed as the Executive Vice President and Chief Financial Officer
of the Company, and the Executive hereby accepts such employment. 
 3. Term of Employment. This Agreement will become
effective on the Effective Date. From and after the Effective Date, this Agreement will govern the Executive’s continued employment by the Company until that employment ceases pursuant to Section 6 (such period of the Executive’s
employment is herein referred to as the “Term of Employment”). Notwithstanding any other provision of this Agreement to the contrary, to the extent that this Agreement has not terminated in accordance with Section 6 prior to the third
anniversary of the first Change in Control (as defined above) that occurs following the Effective Date, this Agreement shall terminate (other than as provided in Section 10.13) on the third anniversary of such Change in Control (with such
termination constituting a “Change in Control Non-renewal”) and, thereafter, the Executive shall become an “at will” employee of the Company. Upon the termination of Executive’s employment occurring on or after a Change in
Control Non-renewal (at which time the Executive will be an “at will” employee of the Company), Executive will not be entitled to any severance payments hereunder, including but not limited to any severance payments to which he may
otherwise have been entitled had his employment been terminated during the thirty-six month period immediately following a Change in Control. 
 4. Positions, Responsibilities and Duties. 
 4.1. Positions. During the Term of Employment, the Executive shall
be employed and serve as the Executive Vice President and Chief Financial Officer of the Company. In such position, the Executive shall have the duties, responsibilities and authority normally associated with the office and position of Executive
Vice President and Chief Financial Officer of a publicly-traded corporation. The Executive shall report to the Board and the chief executive officer. All other accounting, finance and treasury personnel shall report to the Executive and/or his
designees. Notwithstanding the above, the Executive shall not be required to perform any duties and responsibilities which would be likely to result in a non-compliance with or violation of any applicable law or regulation. 
 4.2. Duties. During the Term of Employment, the Executive shall have responsibility for and authority over all accounting, finance and treasury
operations of the Company and its Affiliates. Additionally, during the Term of Employment, the Executive shall devote substantially all of his business time, during normal business hours, to the business and affairs of the Company and the Executive
shall use his reasonable best efforts to perform faithfully and efficiently the duties and responsibilities contemplated by this Agreement; provided, however, that the Executive shall be allowed, 

  

 -4- 

 
to the extent such activities do not substantially interfere with the performance by the Executive of his duties and responsibilities hereunder, to
(a) manage the Executive’s personal, financial and legal affairs, and (b) serve on corporate, civic or charitable boards or committees. 
 5. Compensation and Other Benefits. 
 5.1. Base Salary. During the Term of Employment,
the Executive shall receive a base salary per annum payable in accordance with the Company’s normal payroll practices of no less than US $324,450, which the Board shall review annually and may, in its sole discretion, increase (but not
decrease) (“Base Salary”). 
 5.2. Annual Bonus. During the Term of Employment, the Executive shall participate in the
Company’s Annual Incentive & Management Stock Purchase Plan (the “AIMSPP”) as maintained by the Company from time to time for the benefit of senior executives. In respect of each full or partial calendar year during the Term
of Employment, the Executive shall be eligible for an annual bonus (the “Bonus”) if the Executive and/or the Company achieves performance goals established by the Board in good faith and consistent with the AIMSPP. 
 5.3. Retirement and Savings Plans. During the Term of Employment, the Executive shall be eligible to participate in all pension, retirement,
savings, 401(k) and other employee pension benefit plans, policies and programs (the “Retirement Plans”) maintained by the Company from time to time for the benefit of senior executives and/or other employees. However, nothing in this
Section 5.3 shall be construed to require the Company to establish or maintain any such Retirement Plans. 
 5.4. Supplemental
Executive Retirement Plan. During the Term of Employment, the Executive shall participate in the Company’s Supplemental Executive Retirement Plan (the “SERP”) as maintained by the Company from time to time for the benefit of
senior executives. 
 5.5. Welfare Benefit Plans. During the Term of Employment, the Executive, the Executive’s spouse, if any,
and his eligible dependents, if any, shall be eligible to participate in and be covered on the same basis as other senior executive officers of the Company under all the welfare benefit plans, policies and/or programs maintained by the Company from
time to time including, without limitation, all medical, hospitalization, dental, disability, life, accidental death and dismemberment and travel accident insurance plans, policies and/or programs (the “Welfare Plans”). However, nothing in
this Section 5.5 shall be construed to require the Company to establish or maintain any such Welfare Plans. The Welfare Plans and the Retirement Plans are sometimes referred to collectively herein as the “Benefit Plans.” 

5.6. Expense Reimbursement. During and in respect of the Term of Employment, the Executive shall be entitled to receive prompt reimbursement
for expenses incurred by the Executive in performing his duties and responsibilities hereunder in accordance with the Company’s policy for senior executives of the 

  

 -5- 

 
Company. Notwithstanding anything herein to the contrary or otherwise, except to the extent any expense, reimbursement or in-kind benefit provided pursuant
to Section 5.5 and this Section 5.6 does not constitute a “deferral of compensation” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended from time to time, and its implementing regulations and
guidance (“Section 409A”) (a) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind
benefits provided to the Executive in any other calendar year, (b) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in
which the applicable expense is incurred and (c) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit. 
 5.7. Vacation and Fringe Benefits. During the Term of Employment, the Executive shall be entitled to at least four weeks paid vacation each
calendar year, plus paid time off due to illness or personal reasons in accordance, in all such cases, with Company policy. 
 5.8. Equity
Compensation. During the Term of Employment, the Executive shall be eligible to participate in and receive awards under the Company’s 2007 Stock-Based Incentive Compensation Plan, and any other equity-based incentive plans as maintained by
the Company from time to time for the benefit of senior executives. 
 6. Termination. Upon the occurrence of any termination
of the Executive’s employment as chief financial officer, the Executive shall and shall be deemed to immediately resign from membership on the Board, if applicable, and from any committees thereof (and the Executive shall promptly tender to the
Board a written resignation letter effecting the foregoing). For purposes of determining under Section 409A whether there has been a “separation from service” with the meaning of Treasury Regulation Section 1.409A-1(h) (or any
successor regulation), the Executive shall be deemed to have incurred a separation from service if his employment has been terminated in accordance with Sections 6.1 through Section 6.6 hereof and he is performing less than 20% of the average
level of bona fide services he was performing for the Company in the immediately preceding 36-month period (“Separation From Service”). 
 6.1. Termination Due to Death. In the event of the Executive’s death, the Executive’s estate or his legal representative, as the case may be, shall be entitled to: (a) any Base Salary earned but unpaid as of the date
of death and Base Salary continuation through the end of the month in which the Executive’s death occurs; (b) a pro-rata payment for the year of the Executive’s death equal to the “target” Bonus plus the matching incentive
under the AIMSPP (the “Total Award”) for such year multiplied by a fraction, the numerator which is the number of days transpired in the calendar year up to and including the date of the death of the Executive, and the denominator of which
is 365; (c) immediate payment of any unpaid expense reimbursements and unused accrued vacation days through the date of the Executive’s death; and (d) any other payments and/or benefits which the Executive, the Executive’s estate
or the Executive’s legal representative is entitled to receive under any of the Benefit Plans, the AIMSPP, the SERP or otherwise in accordance with the terms of such plan or arrangement. 
  

 -6- 

 6.2. Termination Due to the Executive’s Disability. Upon 30 days prior written notice to the
Executive, the Company may terminate the Executive’s employment hereunder due to Disability. In such event, the Executive or his legal representative, as the case may be, shall be entitled to: (a) any Base Salary earned but unpaid as of
the date of the Executive’s termination due to Disability and Base Salary continuation through the end of the month in which such termination occurs; (b) a pro-rata payment for the year of termination equal to the Total Award under the
AIMSPP for such year multiplied by a fraction, the numerator of which is the number of days transpired in the calendar year up to and including the date on which the Executive is terminated by the Company due to Disability, and the denominator of
which is 365, payable within 30 days following the date the Separation From Service occurs; (c) immediate payment of any unpaid expense reimbursements and unused accrued vacation days through the date of the Separation From Service; and
(d) any other payments and/or benefits which the Executive or the Executive’s legal representative is entitled to receive under any of the Benefit Plans, the AIMSPP, the SERP or otherwise in accordance with the terms of such plan or
arrangement. 
 6.3. Termination Without Cause or by the Executive for Good Reason Prior to a Change in Control. Prior to a Change in
Control and upon 10 days prior written notice to the Executive, the Company may terminate the Executive’s employment hereunder without Cause. Prior to a Change in Control and upon 30 days prior written notice to the Company the Executive may
terminate his employment hereunder with the Company for Good Reason. In either such event (unless the Executive has incurred a termination under Section 6.1 or 6.2 above), the Executive shall be entitled to, upon execution and effectiveness of
a release in substantially the form attached as Exhibit A: (a) Base Salary earned but unpaid as of the date of the Executive’s termination, (b) a lump sum payment equal to one times Base Salary plus one times the Total
Award under the AIMSPP for the year in which such termination occurs; (c) continuation of medical benefits in effect as of the date of termination for a period of one year following the date of termination at the Company’s sole expense and
following the expiration of this coverage period, COBRA continuation coverage under the Company’s medical plan for 18 months in accordance with applicable law at the Executive’s sole expense provided that the Executive is not enrolled in
another group health plan; provided that to the extent that the foregoing medical benefits are deemed to be a “deferral of compensation” within the meaning of Section 409A, the provision of such benefits will be subject to the second
sentence of Section 5.6; (d) immediate payment of any unpaid expense reimbursements and unused accrued vacation days through the date of termination; and (e) any other payments and/or benefits which the Executive is entitled to
receive under any of the Benefit Plans, the AIMSPP, the SERP or otherwise in accordance with the terms of such plan or arrangement. In the event the Executive intends to terminate his employment with the Company for Good Reason pursuant to this
Section 6.3 or Section 6.4, such prior written notice shall be given to the Company no later than 90 days after the date on which the Executive first becomes aware of the existence of the condition giving rise to Good Reason, and shall
specify the particular act or acts, or failure to act, which is or are the 

  

 -7- 

 
basis for the Executive’s decision to so terminate his employment for Good Reason. The Company shall be given 30 days after such notice to correct such
act or failure to act. Upon failure of the Company, within such 30 day period, to correct such act or failure to act, the Executive may proceed to terminate his employment with the Company and such termination will constitute a termination by the
Executive for Good Reason, provided the Executive terminates employment with the Company no later than 30 days following the expiration of the Company’s cure period. The payments and benefits described in Sections 6.3(b)-(c) will be paid,
or will begin to be paid or provided, as applicable, after the applicable release review period and revocation period have expired, and as if the Executive signed the release on the last day of the release review period. 
 In the event that a Change in Control occurs within six months following the Executive’s termination of employment under this Section 6.3, the
Executive shall be entitled to receive the additional payments and benefits to which he would be entitled had his employment terminated following a Change in Control under Section 6.4 below. 
 6.4. Termination Without Cause or by the Executive for Good Reason After a Change in Control. During the thirty-six (36) month period
immediately following a Change in Control and upon 10 days prior written notice to the Executive, the Company may terminate the Executive’s employment hereunder without Cause. During the thirty-six (36) month period immediately following a
Change in Control and upon 30 days prior written notice to the Company, the Executive may terminate his employment hereunder with the Company for Good Reason. In either such event (unless the Executive has incurred a termination under
Section 6.1 or 6.2 above), the Executive shall be entitled to, upon execution and effectiveness of a release in substantially the form attached as Exhibit A and upon resignation by the Executive from his position, if any, on the Board;
(a) Base Salary earned but unpaid as of the date of the Executive’s termination; (b) a lump sum payment equal to two times Base Salary plus two times the Total Award under the AIMSPP for the year in which any such termination
occurs; (c) continuation of medical benefits in effect as of the date of termination for a period of two years following the date of termination at the Company’s sole expense and following the expiration of this coverage period, COBRA
continuation coverage under the Company’s medical plan for 18 months in accordance with applicable law at the Executive’s sole expense provided that the Executive is not enrolled in another group health plan; provided that to the extent
that the foregoing medical benefits are deemed to be a “deferral of compensation” within the meaning of Section 409A, the provision of such benefits will be subject to the second sentence of Section 5.6; (d) immediate
payment of any unpaid expense reimbursements and unused accrued vacation days through the date of termination; and (e) any other payments and/or benefits to which the Executive is entitled to receive under any of the Benefit Plans, the AIMSPP,
the SERP or otherwise in accordance with the terms of such plan or arrangement. The payments and benefits described in Sections 6.4(b)-(c) will be paid, or will begin to be paid or provided, as applicable, after the applicable release review
period and revocation period have expired, and as if the Executive signed the release on the last day of the release review period. 
 6.5.
Termination For Cause. Subject to the provisions of this Section 6.5, the Company may terminate the Executive’s employment for Cause. In such event, 

  

 -8- 

 
the Executive shall be entitled to: (a) any Base Salary earned but unpaid through the date of termination; (b) immediate payment of any unpaid
expense reimbursements and unused accrued vacation days through the date of termination; and (c) any other payments and/or benefits to which the Executive is entitled to receive under any of the Benefit Plans, the AIMSPP, the SERP or otherwise
in accordance with the terms of such plan or arrangement. In any case described in this Section 6.5, the Executive shall be given written notice authorized by a vote of at least a majority of the members of the Board that the Company intends to
terminate the Executive’s employment for Cause. Such written notice shall specify the particular act or acts, or failure to act, which is or are the basis for the decision to so terminate the Executive’s employment for Cause. Executive
shall be given 30 days after such notice to cure such act or failure to act to the satisfaction of the Board. Upon failure of the Executive, within such 30 day period, to correct such act or failure to act, the Executive shall be deemed terminated
for Cause. 
 6.6. Termination Without Good Reason. Upon 30 days prior written notice to the Company, the Executive shall have the
right to terminate his employment hereunder without Good Reason or any reason at all. In such event, the Executive shall be entitled to: (a) any Base Salary earned but unpaid through the date of termination; (b) immediate payment of any
unpaid expense reimbursements and unused accrued vacation days through the date of termination; and (c) any other payments and/or benefits to which the Executive is entitled to receive under any of the Benefit Plans, the AIMSPP, the SERP or
otherwise in accordance with the terms of such plan or arrangement. 
 6.7. Certain Other Payments. If the Executive is liable for the
payment of any excise tax (the “Basic Excise Tax”) pursuant to Section 4999 of the Code, or any successor or like provision, with respect to any payment or property transfers received or to be received under this Agreement or
otherwise, the Company shall pay the Executive an amount (the “Special Reimbursement”) which, after payment by the Executive (or on the Executive’s behalf) of any federal, state and local taxes, including, without limitation, any
further excise tax under said Section 4999, with respect to or resulting from the Special Reimbursement, equals the net amount of the Basic Excise Tax. The Special Reimbursement shall be paid as soon as possible after it is determined by the
Company or the Executive and reviewed for accuracy by the Company’s certified public accountants, but in all events no later than the last day of the calendar year after the calendar year in which the applicable Basic Excise Tax is paid.

 6.8. Section 409A. Notwithstanding anything to the contrary in this Agreement or elsewhere, if the Executive is a
“specified employee” as determined pursuant to Section 409A as of the date of the Executive’s Separation From Service and if any payment or benefit provided for in this Agreement or otherwise both (x) constitutes a
“deferral of compensation” within the meaning of Section 409A and (y) cannot be paid or provided in the manner otherwise provided without subjecting the Executive to additional tax, interest or penalties under Section 409A,
then any such payment or benefit that is payable during the first six months following the Executive’s Separation From Service shall be paid or provided to the Executive in a cash lump-sum, without interest, on the first business day of the
seventh calendar month following the month in which the Executive’s Separation From Service occurs. In addition, any payment or benefit due 

  

 -9- 

 
upon a termination of the Executive’s employment that represents a “deferral of compensation” within the meaning of Section 409A shall
only be paid or provided to the Executive upon a Separation From Service (as defined above). Notwithstanding anything to the contrary in Section 6 or elsewhere, any payment or benefit under this Section 6, or otherwise, that is exempt from
Section 409A pursuant to Final Treasury Regulation 1.409A-1(b)(9)(v)(A) or (C) shall be paid or provided to the Executive only to the extent that the expenses are not incurred, or the benefits are not provided, beyond the last day of the
second taxable year of the Executive following the taxable year of the Executive in which the Separation From Service occurs; and provided further that such expenses are reimbursed no later than the last day of the third taxable year following the
taxable year of the Executive in which the Separation From Service occurs. Additionally, for the purposes of this Agreement, amounts payable under Section 6 shall be deemed not to be a “deferral of compensation” subject to
Section 409A to the extent provided in the exceptions in Treasury Regulation Sections 1.409A-1(b)(4) (“short-term deferrals”) and (b)(9) (“separation pay plans,” including the exception under subparagraph (iii)) and other
applicable provisions of Treasury Regulation Section 1.409A-1 through A-6. 
 7. Non-exclusivity of Rights. Nothing in
this Agreement shall prevent or limit the Executive’s continuing or future participation in any benefit, bonus, incentive or other plan, policy or program provided or maintained by the Company and/or any Affiliate and for which the Executive
may qualify, nor shall anything herein limit or otherwise prejudice such rights as the Executive may have under any other existing or future agreements with the Company and/or any Affiliate, including, without limitation, any stock option agreements
or plans; provided, however, that any severance compensation and benefits described in Sections 6.1 through 6.4 supersedes any other severance payment for which the Executive may be eligible under the Company’ standard severance plan.
Therefore, the Executive acknowledges and agrees that he is not eligible to receive any severance payment under the Company’s standard severance plan. Amounts which are vested benefits or which the Executive is otherwise entitled to receive
under any plans or programs of the Company and/or any Affiliate at or subsequent to the date of termination shall be payable in accordance with such plans or programs. Notwithstanding the above, the Company shall be under no obligation to establish
or maintain any such plan, policy or program. 
 8. Successors. 
 8.1. The Executive. This Agreement is personal to the Executive and, without the prior express written consent of the Company, shall not be
assignable by the Executive, except that the Executive’s rights to receive any compensation or benefits under this Agreement may be transferred or disposed of pursuant to testamentary disposition, intestate succession or pursuant to a domestic
relations order. This Agreement shall inure to the benefit of and be enforceable by the Executive’s heirs, beneficiaries and/or legal representatives. 
 8.2. The Company. This Agreement shall inure to the benefit of and be binding upon the Company and its respective successors and assigns. The Company shall require any successor to all or substantially all of
its business and/or assets, whether 

  

 -10- 

 
direct or indirect, by purchase, merger, consolidation, acquisition of stock, or otherwise (the “Company’s Successor”), by an agreement in
form and substance satisfactory to the Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent as the Company would be required to perform if no such succession had taken place. 
 9. Restrictive Covenants. 
 9.1. Non-Solicitation. During the Restricted Period, the Executive shall not (except on the Company’s behalf), directly or indirectly, on his own behalf or on behalf of any other person, firm, partnership, corporation or other
entity, (a) solicit or service the business of any of the Company’s or its Affiliates’ clients, any of the Company’s or its Affiliates’ former clients which were clients within twelve months prior to the termination of his
employment or any of the prospective clients which were being actively solicited by the Company or its Affiliates at the time of the termination of his employment or (b) attempt to cause or induce any employee of the Company or its Affiliates
to leave the Company or the Affiliate. 
 9.2. Non-Competition. During the Restricted Period, the Executive shall not, directly or
indirectly, within or with respect to the United States of America engage, without the consent of the Company, in any business or activity, whether as an employee, consultant, partner, principal, agent, representative, stockholder or in any other
capacity, or render any services or provide any advice to any business, activity, person or entity which competes with any PET packaging business; provided, however, that the Executive’s ownership of not more than 5% of the stock of any
publicly-traded corporation shall not be a violation of this Section 9.2. By agreeing to this contractual modification prospectively at this time, the parties intend to make this provision enforceable under the law(s) of all applicable states
so that the entire agreement not to compete and/or this Agreement as prospectively modified shall remain in full force and effect and shall not be rendered void or illegal. Such modifications shall not affect the payments made to the Executive under
this Agreement. The Executive acknowledges that his skills are such that he can be gainfully employed in noncompetitive employment and that the agreement not to compete will in no way prevent him from earning a living. The Executive understands and
agrees that the rights and obligations set forth in this Section 9.2 shall extend beyond the Term of Employment. 
 9.3.
Confidentiality. The Executive shall not, during the Term of Employment and at any time thereafter, without the prior express written consent of the Company, directly or indirectly divulge, disclose or make available or accessible any
Confidential Information (as defined below) to any person, firm, partnership, corporation, trust or any other entity or third party (other than when required to do so in good faith to perform the Executive’s duties and responsibilities under
this Agreement or when (a) required to do so by a lawful order of a court of competent jurisdiction, any governmental authority or agency, or any recognized subpoena power, or (b) necessary to prosecute the Executive’s rights against
the Company or its Affiliates’ or to defend himself against any allegations). In addition, the Executive shall not create any derivative work or other product based on or resulting from any Confidential Information (except in the good faith

  

 -11- 

 
performance of his duties under this Agreement). The Executive shall also proffer to the Board’s designee, no later than the effective date of any
termination of his employment with the Company for any reason, and without retaining any copies, notes or excerpts thereof, all memoranda, computer disks or other media, computer programs, diaries, notes, records, data, customer or client lists,
marketing plans and strategies, and any other documents consisting of or containing Confidential Information that are in the Executive’s actual or constructive possession or which are subject to his control at such time. For purposes of this
Agreement, “Confidential Information” shall mean all information respecting the business and activities of the Company, or any Affiliate of the Company, including, without limitation, the terms and provisions of this Agreement, the
clients, customers, suppliers, employees, consultants, computer or other files, projects, products, computer disks or other media, computer hardware or computer software programs, marketing plans, financial information, methodologies, know-how,
processes, practices, approaches, projections, forecasts, formats, systems, data gathering methods and/or strategies of the Company or any Affiliate. Notwithstanding the immediately preceding sentence, Confidential Information shall not include any
information that is, or becomes, generally available to the public (unless such availability occurs as a result of the Executive’s breach of any portion of this Section 9.3). 
 9.4. Ownership of Inventions. Each Invention (as defined below) made, conceived or first actually reduced to practice by the Executive, whether
alone or jointly with others, during the term of Executive’s employment with the Company and each Invention made, conceived or first actually reduced to practice by the Executive, whether alone or jointly with others, within one year after the
termination of Executive’s employment with the Company which relates in any way to work performed for the Company during the term of Executive’s employment, shall be promptly disclosed in writing to the Board. Such report shall be
sufficiently complete in technical detail and appropriately illustrated by sketch or diagram to convey to one skilled in the art of which the invention pertains, a clear understanding of the nature, purpose, operations, and, to the extent known, the
physical, chemical, biological or other characteristics of the Invention. As used in this Agreement, “Invention” means any invention, discovery or innovation with regard to any facet of the Company’s business whether or not
patentable, made, conceived, or first actually reduced to practice by Executive, alone or jointly with others, in the course of, in connection with, or as a result of service as an employee of the Company, including any art, method, process,
machine, manufacture, design or composition of matter, or any improvement thereof. Each Invention, as herein defined, shall be the sole and exclusive property of the Company. The Executive agrees to execute an assignment to the Company or its
nominee of the Executive’s entire right, title and interest in and to any Invention, without compensation beyond that provided in this Agreement. The Executive further agrees, upon the request of the Company and at its expense, that the
Executive will execute any other instrument and document necessary or desirable in applying for and obtaining patents in the United States and in any foreign country with respect to any Invention. The Executive further agrees, whether or not the
Executive is then an employee of the Company, to cooperate to the extent and in the manner reasonably requested by the Company in the prosecution or defense of any claim involving a patent covering any Invention or any litigation or other claim or
proceeding involving any Invention covered by this Agreement, but all expenses thereof shall be paid by the Company. 
  

 -12- 

 9.5. Injunctive Relief. The Executive acknowledges and agrees that the Company will have no
adequate remedy at law, and would be irreparably harmed, if the Executive breaches or threatens to breach any of the provisions of this Section 9 of this Agreement. The Executive agrees that the Company shall be entitled to equitable and/or
injunctive relief to prevent any breach or threatened breach of this Section 9, and to specific performance of each of the terms of such Section in addition to any other legal or equitable remedies that the Company may have. The Executive
further agrees that he shall not, in any equity proceeding relating to the enforcement of the terms of this Section 9, raise the defense that the Company has an adequate remedy at law. 
 9.6. Special Severability. The terms and provisions of this Section 9 are intended to be separate and divisible provisions and if, for any
reason, any one or more of them is held to be invalid or unenforceable, neither the validity nor the enforceability of any other provision of this Agreement shall thereby be affected. It is the intention of the parties to this Agreement that the
potential restrictions on the Executive’s future employment imposed by this Section 9 be reasonable in both duration and geographic scope and in all other respects. If for any reason any court of competent jurisdiction shall find any
provisions of this Section 9 unreasonable in duration or geographic scope or otherwise, the Executive and the Company agree that the restrictions and prohibitions contained herein shall be effective to the fullest extent allowed under
applicable law in such jurisdiction. 
 10. Miscellaneous. 
 10.1. Applicable Law. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, applied
without reference to principles of conflict of laws. Both the Executive and the Company agree to appear before and submit exclusively to the jurisdiction of the state and federal courts located within Philadelphia, Pennsylvania with respect to any
controversy, dispute, or claim arising out of or relating to this Agreement. The Executive further agrees that the Company may serve him with judicial process via registered or certified mail and that the Chief Executive Officer of the Company shall
at all times be the Executive’s agent for service of judicial process, and the Executive hereby appoints the Chief Executive Officer of the Company as the Executive’s agent for that and any other related purpose. 
 10.2. Full Settlement. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive. In no event shall the Executive be obligated to seek other employment or take any
other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement. The Company agrees to pay, to the full extent permitted by law, all legal fees and expenses which the Executive may reasonably
incur as a result of any contest (regardless of the outcome thereof) by the Company or others of the validity or enforceability of, or liability under, any provision of this Agreement. 
  

 -13- 

 10.3. Amendments. This Agreement may not be amended or modified otherwise than by a written
agreement executed by the parties hereto or their respective successors and legal representatives. 
 10.4. Mutual Intent. Both
parties participated in the drafting of the Agreement, and the language used in this Agreement is the language chosen by the Executive and the Company to express their mutual intent. Both the Executive and the Company agree that in the event that
any language, section, clause, phrase or word used in the Agreement is determined to be ambiguous, no presumption shall arise against or in favor of either party and that no rule of strict construction shall be applied against either party with
respect to such ambiguity. 
 10.5. Notices. All notices and other communications hereunder shall be in writing and shall be given by
hand-delivery to the other parties or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
  

			
	To the Company:	 	Chairman of the Compensation Committee
		 	Constar International Inc.
		 	One Crown Way
		 	Philadelphia, PA 19154
		
	and to	 	Chief Executive Officer
		 	Constar International Inc.
		 	One Crown Way
		 	Philadelphia, PA 19154
		
	 With a copy to Company’s
 counsel at:
	 	Jonathan A. Clark, Esq.
		 	Pepper Hamilton LLP
		 	3000 Two Logan Square
		 	Eighteenth and Arch Streets
		 	Philadelphia, PA 19103-2799
		
	To the Executive:	 	Walter Sobon
		 	1315 McAuley Court
		 	Ambler, PA 19002

 or to such other address as any party shall have furnished to the others in writing in accordance herewith.
Notices and communications shall be effective when actually received by the addressee. 
  

 -14- 

 10.6. Withholding. The Company may withhold from any amounts payable under this Agreement such
federal, state or local taxes to the extent the same are required to be withheld pursuant to any applicable law or regulation. 
 10.7.
Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. 
 10.8. Captions. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. 
 10.9. Counterparts. This Agreement may be executed in one or more counterparts each of which shall be deemed an original instrument, but all of
which together shall constitute but one and the same Agreement. 
 10.10. Beneficiaries/References. The Executive shall be entitled to
select (and change) a beneficiary or beneficiaries to receive any compensation or benefit payable hereunder following the Executive’s death, and may change such election, in either case by giving the Company written notice thereof. In the event
of the Executive’s death, reference in this Agreement to the Executive shall be deemed, where appropriate, to refer to his beneficiary(ies), estate or other legal representative(s). 
 10.11. Entire Agreement. This Agreement contains the entire agreement between the parties concerning the subject matter hereof and supersedes all
prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect thereto. 
 10.12. Representations. 
 10.12.1. Option Awards. The Company represents and warrants to the Executive that all
shares issued pursuant to any equity award granted to the Executive by the Company, upon issuance to the Executive, will be duly authorized, fully paid and non-assessable. A sufficient number of shares for each such equity award will be properly
reserved. 
 10.12.2. Authorization. The Company represents and warrants to the Executive that this Agreement will be authorized by
all necessary action of the Company and will be the binding agreement of the Company, enforceable against it in accordance with the terms thereof. The Company is not prevented from entering into or performing this Agreement by any law, order, rule
or regulation, its certificate of incorporation, bylaws or any agreement to which it is a party. 
 10.12.3. Duties of the Employee.
The Executive represents and warrants that the performance by Executive of the Executive’s duties and obligations under this Agreement will not violate any agreement between the Executive and any other person, firm, partnership, corporation or
other organization. 
  

 -15- 

 10.13. Survivorship. The respective rights and obligations of the parties hereunder shall survive
any termination of this Agreement or the Executive’s Term of Employment hereunder for any reason to the extent necessary to the intended provision of such rights and the intended performance of such obligations. Without limiting the generality
of the first sentence of this Section 10.13, the rights and obligations of Section 9 shall survive the termination of this Agreement. 
 10.14. All Prior Agreements Terminated. Without limiting the generality of Section 10.11, this Agreement terminates and supersedes: (i) the Original Agreement between the Company and the Executive dated December 12,
2005 and any other agreements between the Company and the Executive related to the Executive’s employment by the Company, and (ii) the Constar, Inc. Confidentiality and Trade Secret Protection Agreement between Constar, Inc. and the
Executive dated December 12, 2005. 
 IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and the Company has
caused this Agreement to be executed in its name on its behalf, all as of the day and year first above written. 
  

			
	Constar International Inc.
	
	 /s/ Alec Taylor

	By:	 	Alec Taylor
	
	 /s/ Walter Sobon

	Walter Sobon

  

 -16- 

 EXHIBIT A 
 Release 
 IN CONSIDERATION OF the terms and conditions contained in the Amended and Restated
Executive Employment Agreement, dated as of November 17, 2008, (the “Employment Agreement”) by and between Walter Sobon (the “Executive”) and Constar International Inc. (the “Company”), including, without
limitation, the severance benefits provided in Section 6 of the Employment Agreement, the Executive on behalf of himself and his heirs, executors, administrators, and assigns, releases and discharges the Company and its past present and future
subsidiaries, divisions, affiliates and parents, and their respective current and former officers, directors, employees, agents, and/or owners, and their respective successors, and assigns and any other person or entity claimed to be jointly or
severally liable with the Company or any of the aforementioned persons or entities (the “Released Parties”) from any and all manner of actions and causes of action, suits, debts, dues, accounts, bonds, covenants, contracts, agreements,
judgments, charges, claims, and demands whatsoever (“Losses”) which the Executive and his heirs, executors, administrators, and assigns have, had, or may hereafter have, against the Released Parties or any of them arising out of, related
to or by reason of the Executive’s employment by the Company and the cessation thereof, and any and all Losses arising under any federal, state, or local statute, rule, or regulation, or principle of contract law or common law, including but
not limited to, the Family and Medical Leave Act of 1993, as amended, 29 U.S.C. §§ 2601 et seq., Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. §§ 2000 et seq., the Age Discrimination in Employment Act of 1967,
as amended, 29 U.S.C. §§ 621 et seq. (the “ADEA”), the Americans with Disabilities Act of 1990, as amended, 42 U.S.C. §§ 12101 et seq., the Worker Adjustment and Retraining Notification Act of 1988, as amended, 29
U.S.C. §§ 2101 et seq., the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. §§ 1001 et seq., the Pennsylvania Human Relations Act, as amended, 43 P.S. §§ 955 et. seq., and any other equivalent or
similar federal, state, or local statute; provided, however, that the Executive does not release or discharge the Released Parties from any of the Company’s obligations to him (i) under the Employment Agreement, (ii) for
indemnification under the Company’s By-Laws and/or certificate of incorporation, (iii) under any applicable insurance policies or (iv) for Losses arising under the ADEA which arise after the date on which the Executive executes this
Release. It is understood that nothing in this Release is to be construed as an admission on behalf of the Released Parties of any wrongdoing with respect to the Executive, any such wrongdoing being expressly denied. 
 The Executive represents and warrants that he fully understands the terms of this Release, that he has been encouraged to seek, and has sought, the
benefit of advice of legal counsel, and that he knowingly and voluntarily, of his own free will, without any duress, being fully informed, and after due deliberation, accepts its terms and signs below as his own free act. Except as otherwise
provided herein, the Executive understands that as a result of executing this Release, he will not have the right to assert that the Company or any other of the Released Parties unlawfully terminated his employment or violated any of his rights in
connection with his employment or otherwise. 
  

 A-1 

 The Executive further represents and warrants that he has not filed, and will not initiate, or cause to
be initiated on his behalf any complaint, charge, claim, or proceeding against any of the Released Parties before any federal, state, or local agency, court, or other body relating to any claims barred or released in this Release thereof, and will
not voluntarily participate in such a proceeding. However, nothing in this Release shall preclude or prevent the Executive from filing a claim, which challenges the validity of this Release solely with respect to the Executive’s waiver of any
Losses arising under the ADEA. The Executive shall not accept any relief obtained on his behalf by any government agency, private party, class, or otherwise with respect to any claims covered by this Release. 
 The Executive may take twenty-one (21)/forty-five1 days to consider whether to execute this Release. Upon the Executive’s execution of this Release, the Executive will have seven (7) days after such execution in which he
may revoke such execution. In the event of revocation, the Executive must present written notice of such revocation to the Company’s Chief Executive Officer. If seven (7) days pass without receipt of such notice of revocation, this Release
shall become binding and effective on the eighth (8th) day after the execution hereof (the “Effective Date’). 
 INTENDING TO
BE LEGALLY BOUND, I hereby set my hand below: 
  

			
	 /s/ Walter Sobon

	Walter Sobon
		
	Dated:	 	  

  

							
	State of	  	                                         
 
	 	)	    	
		  		 	)	    	ss.
	County of	  	  
	 	)	    	

 On this      day of
             in the year 200   before me, the undersigned, personally appeared Walter Sobon, personally known to me or proved to me on the basis of satisfactory
evidence to be the individual whose name is subscribed to the within instrument, and acknowledged to me that he executed the same in his capacity as an individual, and that by his signature on the instrument he executed such instrument, and that
such individual made such appearance before the undersigned. 
  

	
	  

	Notary Public

  

	 1
	 As applicable under the ADEA or pursuant to the advice of the Company’s legal counsel.

  

 A-2Form of Stock Option Agreement

 Exhibit 10.1 
 STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT 
 TransDigm Group Incorporated, a Delaware
corporation (the “Company”), pursuant to its 2006 Stock Incentive Plan (the “Plan”), hereby grants to the holder listed below (“Participant”), an option to purchase the number
of shares of the Company’s common stock, par value $0.01 (“Stock”), set forth below (the “Option”). This Option is subject to all of the terms and conditions set forth herein and in the Stock
Option Agreement attached hereto as Exhibit A (the “Stock Option Agreement”) and the Plan, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same
defined meanings in this Grant Notice and the Stock Option Agreement. 
  

			
	Participant:	  	  

		
	Grant Date:	  	  

		
	Exercise Price per Share:	  	 $

		
	Total Number of Shares Subject to the Option:	  	 shares

		
	Expiration Date:	  	  

  

			
	Type of Option:	  	 ̈    Incentive Stock Option             ̈    Non-Qualified Stock Option
		
	Vesting Schedule:	  	Subject to the terms of the Stock Option Agreement (including without limitation all exhibits thereto), the Option shall be eligible to become exercisable upon the achievement of performance
objectives over the period set forth in Exhibit B hereto (provided that the Participant is an Eligible Person (as defined in the Plan) at all times during the period beginning on the Grant Date and ending on the applicable vesting
date):

 By his or her signature, the Participant agrees to be bound by the terms and conditions of the
Plan, the Stock Option Agreement and this Grant Notice. The Participant has reviewed the Stock Option Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant
Notice and fully understands all provisions of this Grant Notice, the Stock Option Agreement and the Plan. The Participant agrees that as a condition to receiving the Option, the Participant shall comply with the Stock Retention Guidelines set forth
on Exhibit C. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or relating to the Option. 
  

							
	TRANSDIGM GROUP INCORPORATED	 	PARTICIPANT
				
	By:	 	  
	 	By:	 	  

	Print Name:	 	  
	 	Print Name:	 	  

	Title:	 	  
	 		 	
	Address:	 	  
	 	Address:	 	  

 EXHIBIT A 
 TO STOCK OPTION GRANT NOTICE 
 STOCK OPTION AGREEMENT 
 Pursuant to the Stock Option Grant Notice (the “Grant Notice”) to which this Stock Option Agreement (this
“Agreement”) is attached, TransDigm Group Incorporated, a Delaware corporation (the “Company”), has granted to the Participant an option (the “Option”)1 under the Company’s 2006 Stock Incentive Plan (the “Plan”) to purchase the number of shares of Stock indicated in the Grant
Notice. 
 ARTICLE I. 
 GENERAL 
 1.1 Defined Terms. Wherever the following terms are used in this Agreement they shall have the meanings
specified below, unless the context clearly indicates otherwise. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice. 
 (a) “Administrator” shall mean the Board or the Compensation Committee or other committee of the Board responsible for conducting
the general administration of the Plan in accordance with Section 3 of the Plan; provided that if the Participant is an Independent Director, “Administrator” shall mean the Board. 
 (b) “Consultant” shall mean an individual who renders services to the Company as a consultant and has been so
designated by the Committee. 
 (c) “Credit Agreement” shall mean that certain credit agreement dated as of
June 23, 2006 among TransDigm, Inc., TransDigm Group Incorporated and the lenders party thereto, as in effect as of the Grant Date and without reference to any amendment to the Credit Agreement made following the Grant Date. 
 (d) “Diluted Shares” as of a given date shall mean the total diluted weighted-average of common shares of the
Company outstanding as of such date. 
 (e) “EBITDA” for a given fiscal year of the Company shall mean Consolidated
EBITDA (as defined in the Credit Agreement) of the Company for such fiscal year on a pro forma basis adjusted for acquisitions or divestitures. 
 (f) “Independent Director” shall mean a non-employee director of the Company. 
 (g)
“Net Debt” shall mean, as of the last day of a given fiscal year of the Company, the excess of (a) Consolidated Total Indebtedness (as defined in the Credit Agreement) of the Company over (b) the amount of cash and
cash equivalents set forth on the Company’s balance sheet. 
 (h) “Termination of Consultancy” shall mean the
time when the engagement of the Participant as a Consultant to the Company or a Subsidiary is terminated for any reason, with or without 
  

	1	For the avoidance of doubt, the term “Option” as used herein only describes options granted pursuant to the Stock Option Grant Notice to which this Agreement is an
Exhibit. 

 cause, including, but not by way of limitation, by resignation, discharge, death or retirement, but excluding:
(i) terminations where there is a simultaneous employment or continuing employment of the Participant by the Company or any Subsidiary, and (ii) terminations where there is a simultaneous re-establishment of a consulting relationship or
continuing consulting relationship between the Participant and the Company or any Subsidiary. The Administrator, in its absolute discretion, shall determine the effect of all matters and questions relating to Termination of Consultancy, including,
but not by way of limitation, the question of whether a particular leave of absence constitutes a Termination of Consultancy. Notwithstanding any other provision of the Plan, the Company or any Subsidiary has an absolute and unrestricted right to
terminate a Consultant’s service at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in writing. 
 (i) “Termination of Directorship” shall mean the time when the Participant, if he or she is or becomes an Independent Director, ceases to be a Director for any reason, including, but not by way
of limitation, a termination by resignation, failure to be elected, death or retirement. The Board, in its sole and absolute discretion, shall determine the effect of all matters and questions relating to Termination of Directorship with respect to
Independent Directors. 
 (j) “Termination of Employment” shall mean the time when the employee-employer relationship
between the Participant and the Company or any Subsidiary is terminated for any reason, with or without Cause, including, but not by way of limitation, a termination by resignation, discharge, death, disability or retirement; but excluding:
(i) terminations where there is a simultaneous reemployment or continuing employment of the Participant by the Company or any Subsidiary, and (ii) terminations where there is a simultaneous establishment of a consulting relationship or
continuing consulting relationship between the Participant and the Company or any Subsidiary. The Administrator, in its absolute discretion, shall determine the effect of all matters and questions relating to Termination of Employment, including,
but not by way of limitation, the question of whether a particular leave of absence constitutes a Termination of Employment; provided, however, that, if this Option is an Incentive Stock Option, unless otherwise determined by the Administrator in
its discretion, a leave of absence, change in status from an employee to an independent contractor or other change in the employee-employer relationship shall constitute a Termination of Employment if, and to the extent that, such leave of absence,
change in status or other change interrupts employment for the purposes of Section 422(a)(2) of the Code and the then applicable regulations and revenue rulings under said Section. 
 (k) “Termination of Services” shall mean the time when (i) every relationship between the Participant and the Company has
been terminated by a Termination of Consultancy, Termination of Directorship and/or Termination of Employment, as applicable, and (ii) the Participant is no longer an Eligible Person under the Plan. 
 1.2 Incorporation of Terms of Plan. The Option is subject to the terms and conditions of the Plan which are incorporated herein by reference. In
the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 
 ARTICLE II. 
 GRANT OF OPTION 
 2.1 Grant of
Option. In consideration of the Participant’s past and/or continued employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the
“Grant Date”), the Company irrevocably grants to the Participant the Option to purchase any part or all of an aggregate of the number of shares of Stock set forth in the Grant Notice, upon the terms and conditions set forth
in the Plan and this Agreement. Unless 
 designated as a Non-Qualified Stock Option in the Grant Notice, the Option shall be an Incentive Stock Option to the
maximum extent permitted by law. 

 2.2 Exercise Price. The exercise price of the shares of Stock subject to the Option shall be as
set forth in the Grant Notice, without commission or other charge; provided, however, that the price per share of the shares of Stock subject to the Option shall not be less than 100% of the Fair Market Value of a share of Stock on the
Grant Date. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Participant owns (within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all classes of
stock of the Company or any “subsidiary corporation” of the Company or any “parent corporation” of the Company (each within the meaning of Section 424 of the Code), the price per share of the shares of Stock subject to the
Option shall not be less than 110% of the Fair Market Value of a share of Stock on the Grant Date. 
 2.3 Consideration to the
Company. In consideration of the grant of the Option by the Company, the Participant agrees to render faithful and efficient services to the Company or any Subsidiary. Nothing in the Plan or this Agreement shall confer upon the Participant any
right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the
services of the Participant at any time for any reason whatsoever, with or without Cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and the Participant. 
 ARTICLE III. 
 PERIOD OF
EXERCISABILITY 
 3.1 Commencement of Exercisability. 
 (a) Subject to Sections 3.1(b), 3.1(c) and 3.3, the Option shall become vested and exercisable in such amounts and at such times as are set forth in the
Grant Notice. 
 (b) No portion of the Option which has not become vested and exercisable at the date of the Participant’s Termination
of Services shall thereafter become vested and exercisable, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and the Participant. 
 (c) Notwithstanding Section 3.1(a) of this Agreement and Section 8 of the Plan (but subject to Section 3.1(b) of this Agreement), in the
event of a Change in Control: Options shall become fully vested and exercisable if the applicable target related to Stockholder Return (as defined below) is attained: (i) if such Change in Control occurs on or prior to September 30, 2009
and the Stockholder Return (as defined below) is at least 50%; (ii) if such Change in Control occurs on or following October 1, 2009 and on or prior to September 30, 2010 and the Stockholder Return is at least 40%; (iii) if such
Change in Control occurs on or following October 1, 2010 and on or prior to September 30, 2011 and the Stockholder Return is at least 30%; or (iv) if such Change in Control occurs on or following October 1, 2011 and on or prior
to September 30, 2013 and the Stockholder Return is at least 20%; provided, however that in no case shall the Options become fully vested unless the Fair Market Value per share on the effective date of a Change in Control is $52.50. For
purposes of this Section 3.1, “Stockholder Return” shall mean the annual compounded pre-tax internal rate of return determined with respect to the period beginning on the Grant Date and ending on the effective date of a
Change in Control (and based upon an assumed fair market value of $35.00 per share on the Grant Date and on the Fair Market Value on the effective date of a Change in Control). For purposes of determining Stockholder Return in 

 
connection with any Change in Control, the following proceeds received by the Company’s stockholder during the period beginning on the Grant Date and
ending on the date of such Change in Control shall be considered: (i) dividends and distributions received by the stockholders from the Company or any of its subsidiaries plus (ii) the Fair Market Value of the consideration received by the
stockholders in connection with a Change in Control or in connection with any other sale of common stock or other equity interests in the Company or any Subsidiary, after taking into account all post-closing adjustments relating to a Change in
Control, and assuming the exercise of all vested options and warrants outstanding as of the effective date of such Change in Control (after giving effect to any dilution of securities or instruments arising in connection with such Change in
Control); provided however, that if the stockholders retain any portion of the common stock following such Change in Control or other sale, the Fair Market Value of such portion of the retained common stock immediately following such Change
in Control or other sale shall be deemed “consideration received” for purposes of calculating the proceeds and provided further that the Fair Market Value of any non-cash consideration (including stock) received in connection with a
Change in Control shall be determined as of the date of such Change in Control. 
 [(d) INCLUDE ONLY FOR THOSE PARTICIPANTS RECEIVING A
280G GROSS UP: Anything in this Agreement to the contrary notwithstanding, if a Change of Control occurs and it is determined that any payment or distribution by the Company to or for the benefit of Participant, whether paid or payable or
distributed or distributable pursuant to the terms of this Agreement or otherwise, including the acceleration of Options hereunder (a “Payment”), would constitute an “excess parachute payment” within the meaning of
Section 280G of the Code, the Company shall pay to the Participant an additional amount (the “Gross-Up Payment”) equal to the amount of any excise tax imposed under Section 4999 of the Code, times a gross-up factor
equal to 1 divided by (1 minus the Total Tax Rate) (but limited in amount to the excise tax that would have been imposed under the Code as in effect on the date hereof), where the “Total Tax Rate” includes any applicable
federal, state and local income tax, employment tax and excise tax for the Participant. For purposes of determining the amount of the Gross-Up Payment, unless the Participant specifies that other rates apply, the Participant shall be deemed to pay
federal income tax and employment taxes at the highest marginal rate of federal income and employment taxation in the calendar year in which the Gross-Up Payment is to be made, and state and local income taxes at the highest marginal rate of
taxation in the state and locality of the Participant’s residence on the Payment date, net of the maximum reduction in federal income taxes that may be obtained from the deduction of such state and local taxes. All determinations to be made
under this paragraph shall be made by the Company’s independent public accountants immediately prior to the Change of Control. Any such determination by the Company’s independent public accountants shall be binding upon the Company and the
Participant. The Company shall pay the Gross-Up Payment to the Participant within ten days after the independent public accountant’s determination of the amount thereof. In any event, the Gross-Up Payment shall be made no later than three and
one-half months following the taxable year in which the Payment occurs. All of the fees and expenses of the independent public accountants in performing the determinations referred to in this paragraph shall be borne solely by the Company. In the
event there is a material change in the Code that negatively impacts the amount of excise tax that would be payable in the event of a Change in Control, the Administrator will revisit the issue of providing a Gross-Up Payment and consider whether
the limitation on the amount of the Gross-Up Payment based on the Code as in effect on the date hereof should be removed or modified.] 
 3.2
Duration of Exercisability. The installments provided for in the vesting schedule set forth in the Grant Notice are cumulative. Each such installment which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant
Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3. 
 3.3 Expiration of Option. The
Option may not be exercised to any extent by anyone after the first to occur of the following events: 
 (a) The expiration of ten years from
the Grant Date; 

 (b) If this Option is designated as an Incentive Stock Option and the Participant owned (within the
meaning of Section 424(d) of the Code), at the time the Option was granted, more than 10% of the total combined voting power of all classes of stock of the Company or any “subsidiary corporation” of the Company or any “parent
corporation” of the Company (each within the meaning of Section 424 of the Code), the expiration of five years from the Grant Date; 
 (c) The opening of business on the day of the Participant’s Termination of Employment by reason of a termination by the Company for Cause; 
 (d) The expiration of six months from the date of the Participant’s Termination of Services, unless such termination occurs by reason of the Participant’s death, Disability or retirement (pursuant to
Section 3.3(e)) or is a termination by the Company for Cause (as defined in Participant’s employment agreement), provided, however, that any portion of this Option that is an Incentive Stock Option shall cease to be an Incentive
Stock Option on the expiration of three months from the Participant’s Termination of Services (and shall thereafter be a Non-Qualified Stock Option), provided, further, that to the extent that the Participant is prohibited from selling
shares of Stock pursuant to the Company’s insider trading policy at all times during such six-month period, with the exception of an open trading window of less than seven days, the Option shall expire on the later of (i) the seventh day
following the opening of the first open trading window thereafter or (ii) the first anniversary of the Participant’s Termination of Services; or 
 (e) The expiration of one year from the date of the Participant’s Termination of Services by reason of (i) the Participant’s death or Disability; or (ii) the retirement, after a minimum of ten
years of service, of a Participant who is at least 55 years old, provided, however, that to the extent that the Participant is prohibited from selling shares of Stock pursuant to the Company’s insider trading policy at all times during
such one-year period, with the exception of an open trading window of less than seven days, the Option shall expire on the seventh day following the opening of the first open trading window thereafter. 
 3.4 Special Tax Consequences. The Participant acknowledges that, to the extent that the aggregate Fair Market Value (determined as of the time the
Option is granted) of all shares of Stock with respect to which Incentive Stock Options, including the Option, are exercisable for the first time by the Participant in any calendar year exceeds $100,000, the Option and such other options shall be
Non-Qualified Stock Options to the extent necessary to comply with the limitations imposed by Section 422(d) of the Code. The Participant further acknowledges that the rule set forth in the preceding sentence shall be applied by taking the
Option and other “incentive stock options” into account in the order in which they were granted, as determined under Section 422(d) of the Code and the Treasury Regulations thereunder. The Participant acknowledges that an Incentive
Stock Option exercised more than three months after the Participant’s Termination of Employment, other than by reason of death or Disability, will be taxed as a Non-Qualified Stock Option. 
 ARTICLE IV. 
 EXERCISE OF OPTION

 4.1 Person Eligible to Exercise. Except as provided in Sections 5.2(b), during the lifetime of the Participant, only the
Participant may exercise the Option or any portion thereof. After the death of the Participant, any exercisable portion of the Option may, prior to the time when the Option becomes unexercisable under Section 3.3, be exercised by the
Participant’s personal representative or by any person empowered to do so under the deceased Participant’s will or under the then applicable laws of descent and distribution. 

 4.2 Partial Exercise. Any exercisable portion of the Option or the entire Option, if then wholly
exercisable, may be exercised in whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 3.3. 
 4.3 Manner of Exercise. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company (or any third party administrator or other person or entity designated
by the Company) of all of the following prior to the time when the Option or such portion thereof becomes unexercisable under Section 3.3: 
 (a) An Exercise Notice in a form specified by the Administrator, stating that the Option or portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator; 
 (b) The receipt by the Company of full payment for the shares of Stock with respect to which the Option or portion thereof is exercised, including
payment of any applicable withholding tax, which may be in one or more of the forms of consideration permitted under Section 4.4; 
 (c)
Any other written representations as may be required in the Administrator’s reasonable discretion to evidence compliance with the Securities Act or any other applicable law, rule, or regulation; and 
 (d) In the event the Option or portion thereof shall be exercised pursuant to Section 4.1 by any person or persons other than the Participant,
appropriate proof of the right of such person or persons to exercise the Option. 
 Notwithstanding any of the foregoing, the Company shall have the right to
specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time. 
 4.4 Method of Payment. Payment of the exercise price, and any applicable withholding tax, shall be by any of the following, or a combination thereof, at the election of the Participant: 
 (a) Cash; 
 (b) Check; 
 (c) Broker-Assisted Cash-less Exercise. With the consent of the Administrator, delivery of a notice that the Participant has placed a market sell
order with a broker with respect to shares of Stock then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate exercise
price; provided, that payment of such proceeds is then made to the Company upon settlement of such sale; 
 (d) Share
Surrender. With the consent of the Administrator, surrender of other shares of Stock which (i) in the case of shares of Stock acquired from the Company, have been owned by the Participant for more than six (6) months on the date of
surrender (or such other minimum length of time as the Administrator determines from time to time to be necessary to avoid adverse accounting consequences or violation of any applicable law, rule or regulation), and (ii) have a Fair Market
Value on the date of surrender equal to the aggregate exercise price of the shares of Stock with respect to which the Option or portion thereof is being exercised; or 

 (e) Net Exercise. With the consent of the Administrator, surrendered shares of Stock issuable upon
the exercise of the Option having a Fair Market Value on the date of exercise equal to the aggregate exercise price of the shares of Stock with respect to which the Option or portion thereof is being exercised. 
 4.5 Conditions to Issuance of Stock Certificates. The shares of Stock deliverable upon the exercise of the Option, or any portion thereof, may be
either previously authorized but unissued shares of Stock or issued shares of Stock which have then been reacquired by the Company. Such shares of Stock shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any
shares of Stock purchased upon the exercise of the Option or portion thereof prior to fulfillment of all of the following conditions: 
 (a)
The admission of such shares of Stock to listing on all stock exchanges on which such Stock is then listed; 
 (b) The completion of any
registration or other qualification of such shares of Stock under any state or federal law or under rulings or regulations of the Securities and Exchange Commission or of any other governmental regulatory body, which the Administrator shall, in its
absolute discretion, deem necessary or advisable; 
 (c) The obtaining of any approval or other clearance from any state or federal
governmental agency which the Administrator shall, in its absolute discretion, determine to be necessary or advisable; 
 (d) The receipt by
the Company of full payment for such shares of Stock, including payment of any applicable withholding tax, which may be in one or more of the forms of consideration permitted under Section 4.4; and 
 (e) The lapse of such reasonable period of time following the exercise of the Option as the Administrator may from time to time establish for reasons of
administrative convenience. 
 4.6 Rights as Stockholder. The holder of the Option shall not be, nor have any of the rights or
privileges of, a stockholder of the Company in respect of any shares of Stock purchasable upon the exercise of any part of the Option unless and until such shares of Stock shall have been issued by the Company to such holder (as evidenced by the
appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment will be made for a dividend or other right for which the record date is prior to the date the shares of Stock are issued, except as
provided in Section 8 of the Plan. 
 ARTICLE V. 
 OTHER PROVISIONS 
 5.1 Administration. The Administrator shall have the power to interpret the
Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and
determinations made by the Administrator in good faith shall be final and binding upon Participant, the Company and all other interested persons. No member of the Committee or the Board shall be personally liable for any action, determination or
interpretation made in good faith with respect to the Plan, this Agreement or the Option. 

 5.2 Option Transferability. 
 (a) Except as otherwise set forth in Section 5.2(b), (i) the Option may not be sold, pledged, assigned or transferred in any manner other than
by will or the laws of descent and distribution, unless and until the shares of Stock underlying the Option have been issued, and all restrictions applicable to such shares of Stock have lapsed. Neither the Option nor any interest or right therein
shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such
disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no
effect, except to the extent that such disposition is permitted by the preceding sentence; and (ii) during the lifetime of Participant, only Participant may exercise the Option or any portion thereof. After the death of Participant, any
exercisable portion of the Option may, prior to the time when the Option becomes unexercisable under Section 3.3, be exercised by Participant’s personal representative or by any person empowered to do so under the deceased
Participant’s will or under the then applicable laws of descent and distribution. 
 (b) Notwithstanding the foregoing, with respect to
Participants who are corporate officers or operating presidents, the Administrator may permit any portion of the Option that is not an Incentive Stock Option to be transferred to, exercised by and paid to certain persons or entities related to such
Participant, including but not limited to members of such Participant’s family, charitable institutions or trusts or other entities whose beneficiaries or beneficial owners are members of such Participant’s family and/or charitable
institutions, or to such other persons or entities as may be expressly approved by the Administrator, pursuant to such conditions and procedures as the Administrator may establish. Any permitted transfer shall be subject to the condition that the
Administrator receive evidence satisfactory to it that the transfer is being made for estate and/or tax planning purposes (or to a “blind trust” in connection with such Participant’s termination of employment or service with the
Company or a Subsidiary to assume a position with a governmental, charitable, educational or similar non-profit institution) and on a basis consistent with the Company’s lawful issue of securities. 
 5.3 Adjustments. The Participant acknowledges that the Option is subject to modification and termination in certain events as provided in this
Agreement and Section 8 of the Plan. 
 5.4 Notices. Any notice to be given under the terms of this Agreement to the Company
shall be addressed to the Company in care of the Secretary of the Company at the address given beneath the signature of the Company’s authorized officer on the Grant Notice, and any notice to be given to Participant shall be addressed to
Participant at the address given beneath Participant’s signature on the Grant Notice. By a notice given pursuant to this Section 5.4, either party may hereafter designate a different address for notices to be given to that party. Any
notice which is required to be given to Participant shall, if Participant is then deceased, be given to the person entitled to exercise his or her Option pursuant to Section 4.1 by written notice under this Section 5.4. Any notice shall be
deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 
 5.5 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.

 5.6 Governing Law; Severability. The laws of the State of Delaware shall govern the
interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 
 5.7 Conformity to Securities Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary
with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, and state securities laws and regulations. Notwithstanding anything herein to the
contrary, the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed
amended to the extent necessary to conform to such laws, rules and regulations. 
 5.8 Amendments, Suspension and Termination. To the
extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board, provided, that, except as may otherwise be provided
by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of the Participant. 
 5.9 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement
shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 5.2, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators,
successors and assigns. 
 5.10 Notification of Disposition. If this Option is designated as an Incentive Stock Option, Participant
shall give prompt notice to the Company of any disposition or other transfer of any shares of Stock acquired under this Agreement if such disposition or transfer is made (a) within two years from the Grant Date with respect to such shares of
Stock or (b) within one year after the transfer of such shares of Stock to him. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other
consideration, by Participant in such disposition or other transfer. 
 5.11 Limitations Applicable to Section 16 Persons.
Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any additional limitations set forth in any applicable
exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, this Agreement shall be
deemed amended to the extent necessary to conform to such applicable exemptive rule. 
 5.12 Not a Contract of Employment. Nothing in
this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries. 
 5.13 Entire Agreement. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the
parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. 
 5.14 Section 409A. Notwithstanding any other provision of the Plan, this Agreement or the Grant Notice, the Plan, this Agreement and the Grant Notice shall be interpreted in accordance with, and 

 
incorporate the terms and conditions required by, Section 409A of the U.S. Internal Revenue Code of 1986, as amended (together with any Department of
Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). The Committee reserves the
right (without the obligation to do so or to indemnify the Participant for the failure to do so) to adopt such amendments to the Plan, this Agreement or the Grant Notice or adopt other policies and procedures (including amendments, policies and
procedures with retroactive effect), or take any other actions, as the Committee determines are necessary or appropriate to exempt the Option from Section 409A or to comply with the requirements of Section 409A and thereby avoid the
penalty taxes under Section 409A. 

 EXHIBIT B 
 VESTING 
 Annual Operational Performance per
Diluted Share1 
  

														
	 	 	Minimum Vesting
(12.5% Growth)	 	 	Maximum Vesting
(20% Growth)
	 Fiscal Year
(A)
	 	% of Shares
Vesting
(B)	 	 	YE Operating
Performance
(per Diluted Share)
(C)	 	 	% of Shares
Vesting
(D)	 	 	YE Operating
Performance
(per Diluted Share)
(E)
	2009	 	3.75	%	 	$	41.77	2	 	15	%	 	$	44.56
	2010	 	3.75	%	 	$	46.99	 	 	15	%	 	$	53.47
	2011	 	3.75	%	 	$	52.87	 	 	15	%	 	$	64.16
	2012	 	3.75	%	 	$	59.48	 	 	15	%	 	$	76.99
	2013	 	3.75	%	 	$	66.91	 	 	15	%	 	$	92.39

 1. Annual Operational Performance Vesting. Effective as of the last day of each of the Company’s
fiscal years 2009-2013 there shall become vested the percentage of shares covered by the Option which is equal to the Annual Amount (as described below). The Options shall become vested and exercisable as of the date that the Administrator verifies
the AOP (as defined below); provided, however, the vesting hereunder will be effective as to Participant as of the end of the fiscal year to which such Annual Amount relates (notwithstanding any termination of Participant’s employment during
the period between the end of such fiscal year and the verification of the AOP and, in such case, notwithstanding the provisions of Section 3.1(b)). For each such fiscal year, the Administrator shall verify the AOP, and shall notify the
Company’s Chief Executive Officer of its determination with respect thereto, within ten business days after the Administrator receives the Company’s audited financial statements for that fiscal year. 
 X. For each year (the “performance year”), the Annual Amount is zero if the Annual Operational Performance per Diluted Share (“AOP”)
with respect to such year is less than the amount 
  
  

	 1
	 As of a given date, the Company’s “Annual Operational Performance per Diluted Share” shall mean the ratio
of (1) the excess of (a) the product of (i) EBITDA and (ii) the Fixed Market Multiple (as defined below) over (b) Net Debt to (2) the Company’s number of Diluted Shares as of such date, where “EBITDA,”
“Net Debt” and “Diluted Shares” have the meanings set forth in the Stock Option Agreement set forth on Exhibit A. For purposes of this Exhibit C, the Fixed Market Multiple shall mean the ratio of (1) the sum of
(a) the product of (i) the average of the closing prices per share of Stock prevailing on each trading day during the last six months of the Company’s 2008 fiscal year and (ii) the Company’s number of Diluted Shares as of
September 30, 2008 and (b) Net Debt as of such date to (2) the Company’s EBITDA as of such date. 

	 2
	 Calculated at the end of the Company’s 2008 fiscal year, based on the Annual Operational Performance per Diluted
Share as of September 30, 2008, increased by 12.5% per year for purposes of column (C) and by 20% per year for purposes of Column (E). The fiscal 2008 Annual Operational Performance per Diluted Share is $37.13. May be
recalculated for future grants based on future year’s Annual Operational Performance per Diluted Share. 

 indicated for such year in column (C) and otherwise shall be equal to the amount indicated for such year in column
(B) plus the product of (a) the excess of (1) the amount indicated for such year in column (D) over (2) the amount indicated for such year in column (B) and (b) the ratio of (1) the excess of (x) the AOP
with respect to the year (but not more than the amount indicated in Column (E) for such year) over (y) the amount indicated for such year in column (C) to (2) the excess of (x) the amount indicated for such year in column
(E) over (y) the amount indicated for such year in column (C). 
 Y. In calculating the AOP in Section X. above for any performance
year there shall also be taken into account any AOP in any of the two prior performance years (starting in fiscal year 2009) which was in excess of the amount indicated in Column (E) for such prior year and has not previously been taken into
account hereunder but only if doing so would increase the Annual Amount in such performance year. 
 Z. If the Annual Amount in any
performance year is less than the amount indicated in column (D) for such year then an amount equal to the excess of (1) the amount indicated in column (D) for such year over (2) the actual Annual Amount for such year may vest in
one or more of the next two following years by treating as AOP in the performance year under Section X. above any excess of AOP in one of such following years over the amount indicated in column (E) for the applicable following year. The
portion of any excess AOP amount which is so used may not be used more than once. 
 2. Cumulative Operational Performance Vesting. 
 Effective on the last day of the Company’s fiscal year 2013, there shall become vested the percentage of shares covered by the Option which is equal
to the Cumulative Operational Amount (as defined below). The Options shall become vested and exercisable as of the date that the Administrator verifies the Cumulative Operational Amount; provided, however, the vesting hereunder will be effective as
to Participant as of the end of the fiscal year to which such cumulative amount relates (notwithstanding any termination of Participant’s employment during the period between the end of such fiscal year and the verification of the Cumulative
Operational Amount and, in such case, notwithstanding the provisions of Section 3.1(b)). For each such fiscal year, the Administrator shall verify the Cumulative Operational Amount, and shall notify the Company’s Chief Executive
Officer of its determination with respect thereto, within ten business days after the Administrator receives the Company’s audited financial statements for that fiscal year. 
 The Cumulative Operational Amount shall mean the percentage of shares of Stock covered by the Option equal to3: 
 (a) Zero if the Cumulative Operational Performance per Diluted Share is
less than $268.02. 
 (b) Six and one-quarter percent (6.25%) if the Cumulative Operational Performance per Diluted Share is $268.02.

 (c) Twenty-five percent (25%) if the Cumulative Operational Performance per Diluted Share is at least $331.57. 
 If the Cumulative Operational Performance per Diluted Share is between $268.02 and $331.57, the Cumulative Operational Amount shall be determined by
means of linear interpolation. 
  

	3	Amounts equal the sum of the minimum and maximum columns in the Annual Operational Performance per Diluted Share table. May be recalculated for future grants based on future
year’s Annual Operational Performance per Diluted Share. 

 3. Adjustments of Operational Performance Objectives. The Operational Performance targets specified in this
Exhibit B are based upon certain revenue and expense assumptions about the future business of the Company as of the date the Option is granted. Accordingly, in the event that, after such date, the Administrator determines, in its sole
discretion, that any acquisition or disposition of any business by the Company or any dividend or other distribution (whether in the form of cash, Stock, other securities or other property), recapitalization, reclassification, stock split, reverse
stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Stock or other securities of the Company, issuance of warrants or other rights to purchase Stock or other securities of the Company, any
unusual or nonrecurring transactions or events affecting the Company, or the financial statements of the Company, or change in applicable laws, regulations, or accounting principles occurs such that an adjustment is determined by the Administrator
to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan or with respect to the Option, then the Administrator may, in good faith and in such manner as it may
deem equitable, adjust the amounts set forth on this Exhibit B (and/or adjust the definitions of EBITDA and Net Debt) to reflect the projected effect of such transaction(s) or event(s) on Operational Performance. 

 EXHIBIT C 
 STOCK RETENTION GUIDELINES 
 As a condition to receiving the Option grant, Participant acknowledges
and agrees to hold a number of shares and/or options with such value and for such period of time as set forth below: 
 (a) At all times
during Participant’s continued employment by the Company, Participant shall hold an aggregate amount of Company equity with a value equal to or greater than $             (the
“Retention Limit”). 
 For purposes of this Exhibit C, Company equity shall be calculated in accordance with this
paragraph. Vested options then held by Participant that were originally granted to Participant and his Permitted Transferees pursuant to the Company’s 2003 Stock Option Plan (the “2003 Options”) shall be deemed to have a value
equal to the value of the options (assuming, for such purpose, that the value of the Stock upon exercise is equal to the Deemed Value (as hereinafter defined)) over the exercise price. From time to time, Participant may be required to convert
options into shares of Stock for tax planning, because of their pending expiration or for other reasons. In that case, the shares of Stock then owned by Participant and his Permitted Transferees (other than shares described in (b) below), shall
have a “Deemed Value” of $35.26 per share and the portion of the Retention Limit not covered by the value of the 2003 Options shall be reduced and calculated on a “tax effected basis” (at a 40% aggregate tax rate)4 in accordance with the example set forth on Attachment 1.  
 (b) At all times during Participant’s continued employment by the Company, Participant and his Permitted Transferees shall hold that number of shares of Stock acquired upon exercise of New Options and vested New
Options (treating each share of Stock covered by a New Option as an individual New Option) equal to 30% of the total of the New Options that have vested since the date of grant. For this purpose, “New Options” are options granted to
Participant pursuant to the Company’s 2006 Stock Incentive Plan. 
 (c) Participant’s failure to hold that number of shares and/or
vested options set forth in Sections (a) and (b) of this Exhibit C shall result in Participant’s forfeiture of all unvested New Options unless otherwise determined by the Administrator, in its sole discretion. 
 In order to effectuate the foregoing, Participant agrees to comply with the Company’s Stock Retention Guidelines, if any, as in effect from time to
time (which Stock Retention Guidelines shall not be materially inconsistent with this Exhibit C). 
  

	4	Amount may be changed in the future at the discretion of the Administrator based on significant changes in the Internal Revenue Code.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00150-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00150-of-00352.parquet"}]]